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Cervical spondylotic myelopathy (CSM) refers to impaired function of the spinal cord caused by degenerative changes of the
cervical spine resulting in spinal cord compression. It is the most common disorder in the United States causing dysfunction of the
spinal cord. A literature review of the natural history of mild cervical myelopathy is undertaken. Clinical presentation and current
concepts of pathophysiology are also discussed. While many patients with mild signs of CSM will stabilize or improve over time
with conservative treatment, the clinical course of a speciﬁc individual patient cannot be predicted. Asymptomatic patients with
cervical stenosis and abnormalities on electrophysiologic studies may be at higher risk for developing myelopathy.
1. Natural History of Mild Cervical
Spondylotic Myelopathy
Cervical spondylosis refers to osteoarthritic degeneration of
the cervical spine. Brain et al. suggested symptomatology,
whether radiculopathy or myelopathy, resulted from disc
protrusionandassociatedsofttissueabnormalities[1,2].Al-
though degeneration can occur secondary to various causes,
years of motion and activity, commonly referred to as “wear
and tear,” is the most common etiology. Several studies have
shown in animal models and in humans that excessive mo-
tion and repetitive micro-trauma accelerates degenerative
changes [3–9]. The accumulation of degenerative changes
aﬀects both canal diameter and sagittal mobility of the cer-
vical spine [10]. Additionally, a congenitally narrow spinal
canal may predispose one to formation of CSM [11–14]. In
currentunderstanding,cervicalspondylosisencompassesde-
generative changes aﬀecting the uncovertebral joints, facet
joints, intervertebral discs, and the other soft tissue and bony
components of the cervical spine. While it may aﬀect only a
single level, spondylosis has been shown to commonly begin
at lower levels with subsequent progressive involvement of
multiple spinal levels [15].
While the recommendation for surgical treatment of pa-
tients with severe, progressive myelopathy seems straightfor-
ward, it is less clear how to properly manage patients with
cervical spondylosis and very subtle signs of myelopathy.
Several authors have described the clinical course of patients
with symptomatic cervical spondylosis. Initial authors sup-
portedclinicalstabilityinthispatientpopulation.Clarkeand
Robinson retrospectively described 120 patients with CSM,
26 of whom were treated conservatively [16]. Nearly 80%
of these patients presented with weakness or sensory loss in
one or more limbs, while 18% presented with pain. Clarke
and Robinson showed that approximately 75% of patients
showed episodic progression of symptoms with interven-
ing stability, though approximately two-thirds of patients
showed subtle clinical decline during periods of stability.
In 20% of patients, slow and steady deterioration occurred.
In 5%, onset of symptoms and signs was followed by a
long period of stability without any additional deterioration.
Overall, approximately half of the conservatively managed
patients improved at some point in the clinical course [16].
Lees and Turner described 44 patients with CSM and 51
patientswithspondylosiswithoutmyelopathy[17].Ofthe44
patients with CSM, 28 patients were managed conservatively
with a cervical collar, with 17 showing improvement over
time [17]. In contrast to the authors listed above, several
other groups have suggested that CSM has a largely progres-
sive course over time [18, 19]. Matsumoto et al. described
a case series in which one-third of patients with mild CSM2 Advances in Orthopedics
had progression of symptoms while undergoing conservative
management [20]. Sadasivan et al. reported 22 patients with
CSM of several years duration, all of whom suﬀered clinical
progression of disease over time [21]. It is important to note
thatthestudiesdescribedabovetendedtowardspatientswith
mildandmoderatediseaseprocesses,althoughsomeseverely
aﬀected individuals were also included.
With the creation and subsequent modiﬁcation of the
Japanese Orthopedic Association score for myelopathy [22–
24], a statistically valid and reproducible method of assess-
ing CSM allowed further characterization of this patient
population. Kada ˇ nka et al. suggested that 80% of patients
with mild myelopathy will improve with or without surgery
[25, 26]. Shimomura et al. produced similar results, with
80% of patients showing clinically stable myelopathy over a
3-year period [27]. Other authors have found similar results
with conservative management [28, 29]. However, subjective
self-assessment and general health may decline over time,
aﬀectingtherecommendationofconservativeversussurgical
intervention [30].
Because of the varied nature of progression in mild
myelopathy, several authors have investigated other methods
for identifying patients with either cervical spondylosis or
mild cervical spondylotic myelopathy with higher risk of
progression to moderate or severe myelopathy. Asympto-
matic spondylotic patients with abnormal somatosensory
evoked potentials and radiculopathy have shown increased
propensity to progress towards clinical myelopathy [31–34].
Interestingly, in their study regarding electrophysiologic
ﬁndingsaﬀectingprogressionfromasymptomaticstenosisto
CSM,thedegreeofcompressionasmeasuredbytheanterior-
posterior diameter divided by transverse diameter did not
aﬀect development of CSM [32].
Review of the literature shows that the clinical course of
cervical myelopathy is variable and that conservative man-
agementmayresultinstabilityorimprovementofsymptoms
inthemajorityofpatientswithmildsymptoms[25–29].Pre-
dictingtheclinicalcourseofasinglepatientremainsdiﬃcult,
though some evidence suggests that younger patients and
those with mild symptoms are more likely to improve [35].
2.Pathology of CSM
Severalauthorshavedescribedpathologicﬁndingsassociated
with CSM in cadaveric studies of patients with CSM [36–
38]. Pathologic ﬁndings include atrophy, neuronal loss in
gray matter, and demyelination in the surrounding white
matter.Interestingly,theseﬁndingsaresimilartothosefound
in patients with transient hypoperfusion. The magnitude of
pathologic ﬁndings correlates with the length of myelopathy
and directly relates to the degree of canal stenosis [36–38].
Several authors have found that imaging ﬁndings including
diﬀusion tensor imaging and apparent diﬀusion coeﬃcient
maps also show white-matter tract changes at the corre-
sponding levels of compression [39–41].
3. ClinicalPresentations
CSM may present with divergent clinical ﬁndings depending
on the levels aﬀected, involvement of the neural foramina,
and long tract involvement. A variety of neurological signs
and symptoms may be present, including sensory changes,
reﬂex abnormalities, decreased dexterity, weakness, gait
instability, bowel and bladder dysfunction, spasticity, pres-
ence of Hoﬀman’s and/or Babinski’s sign, axial neck pain,
radiculopathy, and even acute spinal cord injury [42–44].
The variation in symptoms caused by involvement of the
various cervical levels results in a large possibility of clinical
presentations aﬀecting almost any muscle of the body.
Some authors have attempted to distinguish the various
presentations into a categorization schema. Crandall and
Batzdorf suggested clinical grounds for classifying patients
into transverse lesion syndrome, motor system syndrome,
central cord syndrome, Brown-Sequard syndrome, and
brachialgia and cord syndrome [45]. Other authors have
separated the varying presentations: anatomic involvement,
with a lateral or radicular syndrome, medial or myelopathy
syndrome, a combined medial and lateral syndrome, a vas-
cular syndrome, and an anterior syndrome [46, 47]. Most
frequently, clinicians rely on clinical signs and symptoms of
myelopathy rather than the syndrome names above to de-
scribeapatient’scondition.Severityofsymptoms,functional
impairment, and progression of symptoms rather than clin-
ical syndrome classiﬁcation drive decision-making for thera-
peutic interventions.
As radiographic studies have improved and expanded in
use, more patients will likely come for evaluation with ra-
diographic diagnosis of cervical stenosis. Secondary to the
explosion of imaging technology and utilization, the patient
population seen in spine clinics today may represent a slight-
ly diﬀerent population than in the past. Given the variability
of symptom progression, clinical experience and care should
guide management of these patients towards conservative
management.
4. Conclusion
Cervical spondylotic myelopathy occurs in age-dependent
fashion as degenerative changes occur in the cervical spinal
cord. Presenting signs and symptoms are highly variable and
may stabilize or improve over time with conservative man-
agement. Abnormal electrophysiology and presence of radic-
ulopathy may portend an increased chance of progression
from asymptomatic cervical spondylosis to myelopathy.
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